Overactive Bladder
What do we know and not know about mirabegron, a novel β3 agonist, in the treatment of overactive bladder? - Abstract
August 30, 2013
Overactive bladder in elderly men: Epidemiology, evaluation, clinical effects, and management - Abstract
August 28, 2013
Examining mechanisms of brain control of bladder function with resting state functional connectivity MRI - Abstract
August 23, 2013
The efficacy and safety of mirabegron in treating OAB: A systematic review and meta-analysis of phase III trials - Abstract
August 21, 2013
OnabotulinumtoxinA improves quality of life in patients with neurogenic detrusor overactivity - Abstract
August 20, 2013
Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy - Abstract
August 15, 2013
Management of OAB in those over age 65 - Abstract
August 14, 2013
New therapies in the treatment of overactive bladder - Abstract
August 13, 2013
Persistence with first line anticholinergic medication in treatment-naïve overactive bladder patients - Abstract
August 9, 2013
Increased bladder wall thickness in diabetic and nondiabetic women with overactive bladder - Abstract
August 2, 2013
Oestrogens and overactive bladder - Abstract
August 1, 2013